Mobia Medical Inc(MOBI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 5 at 5:44 PM ET (Korea 11/6 07:44)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | - | Insider Own | 61.97% | Shs Outstand | 33.3M | Perf Week | 0.09% |
| Market Cap | 0.38B | Forward P/E | - | EPS next Y | 25.31% | Insider Trans | 8.04% | Shs Float | 12.7M | Perf Month | 32.55% |
| Enterprise Value | 0.21B | PEG | - | EPS next Q | -0.55 | Inst Own | 18.18% | Short Float | 6.72% | Perf Quarter | -7.84% |
| Income | - | P/S | - | EPS this Y | 94.61% | Inst Trans | 32.01% | Short Ratio | 4.2 | Perf Half Y | - |
| Sales | - | P/B | 2.18 | EPS next 5Y | 65.8% | ROA | - | Short Interest | 0.85M | Perf YTD | -19.43% |
| Book/sh | 5.19 | P/C | 2.12 | EPS past 3/5Y | - | ROE | - | 52W High | -26.23% ($15.29) | Perf Year | - |
| Cash/sh | 5.32 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 40.47% ($8.03) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 9.86% 7.32% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.82 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 12.8 | EPS Q/Q | - | Profit Margin | - | RSI (14) | 60.5 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 13.28 | Sales Q/Q | - | SMA20 | 14.49% ($9.85) | Beta | - | Target Price | $17.75 |
| Payout | - | Debt/Eq | 0.05 | Earnings | 2026/11/5 | SMA50 | 12.96% ($9.99) | Rel Volume | 0.91 | Prev Close | $11.24 |
| Employees | 167 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | -13.04% 11.26% | SMA200 | -1.13% ($11.41) | Avg Volume(3M) | 0.20M | Price | $11.28 |
| IPO | 2026/5/8 | Option/Short | No/Yes | Trades | 2123 | Volume | 183,647 | Change | 0.36% |
🧠 MicroPort Scientific subsidiary Mobio Medical is a U.S.-based neuromodulation company that develops and sells vagus nerve stimulation (VNS) medical devices designed to aid motor function rehabilitation in patients suffering from chronic ischemic stroke. Its flagship product, the Vivistim system, is paired with rehabilitation therapy to support upper-limb motor recovery and is being rolled out primarily through stroke centers across the United States.
Over the past 1 year, roughly in the middle
26% below its 1-year high.
Traded about as much as usual. That is 91% of its average volume.
Earnings are growing steadily
Earnings are expected to grow by +94.6% this year.
Tap to view numbers
Not enough quarters to judge yet
Only 2 quarter(s) reported, so no grade yet.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Long-term returns are roughly flat
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 18.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
MSSM Morgan Stanley Pathway Small-Mid Cap Equity ETF <0.01% 
SCHA Schwab U.S. Small-Cap ETF <0.01% 
VTHR Vanguard Russell 3000 Index ETF <0.01% 
VTI Vanguard Morningstar Total Stock Market ETF <0.01% 
VTWG Vanguard Russell 2000 Growth Index ETF <0.01% Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
HAIL State Street SPDR S&P Kensho Smart Mobility ETF 16M It ranks #64 of 140 in the industry
Based on market cap of $376M.
FAQ
What kind of company is MOBI?
MOBI belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of MOBI?
The market cap of MOBI is approximately $376M, ranking 3,362 within its sector.
What is the 52-week high and low for MOBI?
MOBI has recorded a 52-week high of $15.29 and a low of $8.03.
